Details for New Drug Application (NDA): 075303
✉ Email this page to a colleague
The generic ingredient in LABETALOL HYDROCHLORIDE is labetalol hydrochloride. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the labetalol hydrochloride profile page.
Summary for 075303
| Tradename: | LABETALOL HYDROCHLORIDE |
| Applicant: | Hikma |
| Ingredient: | labetalol hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 075303
| Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 075303
Suppliers and Packaging for NDA: 075303
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LABETALOL HYDROCHLORIDE | labetalol hydrochloride | INJECTABLE;INJECTION | 075303 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9320 | 0143-9320-01 | 1 VIAL in 1 BOX, UNIT-DOSE (0143-9320-01) / 20 mL in 1 VIAL |
| LABETALOL HYDROCHLORIDE | labetalol hydrochloride | INJECTABLE;INJECTION | 075303 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9622 | 0143-9622-01 | 1 VIAL in 1 BOX, UNIT-DOSE (0143-9622-01) / 20 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/ML | ||||
| Approval Date: | May 28, 1999 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
